Table 5. Risk factors affecting clinical P. falciparum episodes in Dielmo village (model residuals shown in Figure S1).

Fixed effects	Estimate	Standard Error	z value	p-value
Intercept	−1.39	0.36	−3.91	9.22 10−05
NbprPFA_1–2*	0.90	0.14	6.56	5.46 10−11
NbprPFA_3–5	1.55	0.14	10.735	<2.0 10−16
NbprPFA_6–9	2.06	0.15	13.84	<2.0 10−16
NbprPFA_10–12	2.16	0.17	12.54	<2.0 10−16
NbprPFA_13–16	2.29	0.18	12.99	<2.0 10−16
NbprPFA_17–21	2.52	0.18	13.84	<2.0 10−16
NbprPFA_22–27	2.56	0.19	13.59	<2.0 10−16
NbprPFA_28–34	2.21	0.21	10.77	<2.0 10−16
NbprPFA_35–45	2.61	0.22	11.74	<2.0 10−16
NbprPFA_46–55	2.30	0.25	9.05	<2.0 10−16
NbprPFA_56–89	2.76	0.30	9.09	<2.0 10−16
Age**	−0.33	0.02	−17.39	<2.0 10−16
Days of presence	0.01	0.004	3.15	1.62 10−−03
Drug period 2	0.25	0.14	1.835	0.07
Drug period 3	−0.62	0.16	−3.79	1.51 10−04
Drug period 4	−0.88	0.17	−5.09	3.56 10−07

Random effects: Std. Dev._individuals = 0.58 (n = 285); Std. Dev._house = 0.00 (n = 32).

^*The numbers after NbprPFA (Number of previous P. falciparum clinical episodes) give the range of the number of previous P. falciparum clinical episodes.

^**No significant interaction between Age and Drug period.